UBS Group’s DarioHealth DRIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $917 | Sell |
139
-15,762
| -99% | -$117K | ﹤0.01% | 9692 |
|
|
2026
Q1 | $128K | Buy |
15,901
+15,656
| +6,390% | +$163K | ﹤0.01% | 6886 |
|
|
2025
Q4 | $2.79K | Buy |
245
+106
| +76% | +$1.4K | ﹤0.01% | 9226 |
|
|
2025
Q3 | $2.41K | Sell |
139
-2,253
| -94% | -$24.8K | ﹤0.01% | 9175 |
|
|
2025
Q2 | $32.1K | Buy |
2,392
+93
| +4% | +$1.29K | ﹤0.01% | 8111 |
|
|
2025
Q1 | $28.1K | Buy |
2,299
+2,046
| +809% | +$28.9K | ﹤0.01% | 7990 |
|
|
2024
Q4 | $3.98K | Buy |
+253
| New | +$4.38K | ﹤0.01% | 8807 |
|
|
2024
Q3 | – | Sell |
-3,866
| Closed | -$78.4K | – | 9411 |
|
|
2024
Q2 | $92K | Buy |
3,866
+3,583
| +1,266% | +$102K | ﹤0.01% | 6228 |
|
|
2024
Q1 | $8.67K | Buy |
283
+187
| +195% | +$7.09K | ﹤0.01% | 7318 |
|
|
2023
Q4 | $3.3K | Buy |
96
+78
| +433% | +$2.78K | ﹤0.01% | 7991 |
|
|
2023
Q3 | $1.16K | Buy |
18
+5
| +38% | +$337 | ﹤0.01% | 8070 |
|
|
2023
Q2 | $1.01K | Hold |
13
| – | – | ﹤0.01% | 8040 |
|
|
2023
Q1 | $1.03K | Sell |
13
-250
| -95% | -$24.6K | ﹤0.01% | 8838 |
|
|
2022
Q4 | $22.5K | Buy |
263
+162
| +160% | +$14.6K | ﹤0.01% | 7533 |
|
|
2022
Q3 | $9K | Buy |
101
+88
| +677% | +$9.45K | ﹤0.01% | 8569 |
|
|
2022
Q2 | $2K | Sell |
13
-217
| -94% | -$25.5K | ﹤0.01% | 9530 |
|
|
2022
Q1 | $26K | Sell |
230
-102
| -31% | -$16.9K | ﹤0.01% | 7134 |
|
|
2021
Q4 | $86K | Buy |
332
+119
| +56% | +$36.2K | ﹤0.01% | 6450 |
|
|
2021
Q3 | $58K | Buy |
213
+187
| +719% | +$54K | ﹤0.01% | 6214 |
|
|
2021
Q2 | $11K | Sell |
26
-248
| -91% | -$94.4K | ﹤0.01% | 7962 |
|
|
2021
Q1 | $106K | Buy |
274
+89
| +48% | +$40.1K | ﹤0.01% | 5922 |
|
|
2020
Q4 | $53K | Buy |
185
+11
| +6% | +$2.84K | ﹤0.01% | 6129 |
|
|
2020
Q3 | $58K | Buy |
174
+31
| +22% | +$8.39K | ﹤0.01% | 5539 |
|
|
2020
Q2 | $18K | Buy |
+143
| New | +$19K | ﹤0.01% | 6616 |
|
|
2019
Q4 | – | Sell |
-8
| Closed | -$1K | – | 8157 |
|
|
2019
Q3 | $1K | Sell |
8
-3
| -27% | -$519 | ﹤0.01% | 7823 |
|
|
2019
Q2 | $2K | Sell |
11
-10
| -48% | -$2.6K | ﹤0.01% | 7608 |
|
|
2019
Q1 | $6K | Buy |
+21
| New | +$6.24K | ﹤0.01% | 7076 |
|
|
2018
Q4 | – | Sell |
-20
| Closed | -$8K | – | 8082 |
|
|
2018
Q3 | $8K | Buy |
+20
| New | +$9.18K | ﹤0.01% | 7273 |
|
|
2018
Q1 | – | Sell |
-9
| Closed | -$6K | – | 7882 |
|
|
2017
Q4 | $6K | Buy |
+9
| New | +$6.09K | ﹤0.01% | 7292 |
|
|
2017
Q1 | – | Sell |
-5
| Closed | -$6K | – | 7705 |
|
|
2016
Q4 | $6K | Buy |
5
+1
| +25% | +$1.31K | ﹤0.01% | 7147 |
|
|
2016
Q3 | $6K | Sell |
4
-3
| -43% | -$4.71K | ﹤0.01% | 7044 |
|
|
2016
Q2 | $14K | Buy |
+7
| New | +$14.3K | ﹤0.01% | 6564 |
|
Other funds holding DRIO
NCM
UBS Group's DRIO Position: Q2 2026 in Review
UBS Group reduced its DarioHealth (DRIO) stake by 99% in Q2 2026, selling an estimated $117K and leaving 139 shares worth $917. The position accounts for ﹤0.01% of the portfolio, ranked #9692.
UBS Group first reported a position in DRIO in Q2 2016 and has held it in 32 quarters since. The position peaked at $128K in Q1 2026. 21 funds tracked by Wall St. Rank hold DRIO as of Q2 2026.
- UBS Group held 139 shares of DarioHealth worth $917 as of Q2 2026.
- UBS Group sold 15,762 DarioHealth shares in Q2 2026, an estimated $117K.
- DarioHealth made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9692 holding.
- UBS Group first reported a position in DarioHealth in Q2 2016 and has held it in 32 quarters since.
- UBS Group's DarioHealth position peaked at $128K in Q1 2026.
- 21 funds tracked by Wall St. Rank held DarioHealth as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.